Answers are grounded in this paper and cite their sources.
In this study, we showed that the proinflammatory cytokine response in SAP is an early event, with subsequent downregulation of proinflammatory cytokines beginning at day 1 of symptom onset. Our findings underscore the importance of enrolling subjects very early in the disease course when conducting studies to investigate early immune events of SAP; this current study also serves as an important reference for the design of future biomarker studies and therapeutic trials in SAP.
No takes yet. Share an insight, caveat, or question.
Greer et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: